Decisions in case of "problematic" cost-effectiveness ratios based on the example of a clinical trial in rehabilitation care;Entscheidungen bei "schwierigen" kosteneffektivitä tsrelationen am beispiel eines klinischen versuchs aus der rehabilitation

Gesundheitswesen

Volumn 68, Issue 4, 2006, Pages 249-256

  Leidl, Reiner ^a,b   Jacobi, E ^c   Knab, J ^d   Schweikert, B ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Federseeklinik   (Germany)

Author keywords

Bootstrap; Chronic low back pain; Cost effectiveness plane; Cost utility analysis; Rehabilitation

Indexed keywords

ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH SURVEY; HUMAN; LOW BACK PAIN; MEDICAL DECISION MAKING; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; REHABILITATION CARE; REHABILITATION CENTER;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MODELS, ECONOMIC; REHABILITATION CENTERS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33744912001     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926717     Document Type: Article

References (27)

1. Arrow KJ, Lind RC. Risk and uncertainty. Uncertainty and the evaluation of public investment decisions. American Economic Review 1970; 60: 364-378
2. Becker A, Seitz R, Jacobi E et al. Kostenmessung durch Patientenbefragung. Pilotstudie zu einem Kostenwochenbuch. Rehabilitation 2001; 40(1): 12-20
3. Ben-Zion U, Gafni A. Evaluation of public investment in health care. Is the risk irrelevant? Journal of Health Economics 1983; 2: 161-165
4. Bolten W, Kempel-Waibel A, Pforringer W. Analyse der Krankheitskosten bei Rückenschmerzen. Medizinische Klinik 1998; 93 (6): 388-393
5. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health 2002; 23: 377-401
6. Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Statistics in Medicine 1999; 8 (23): 3245-3262
7. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non- parametric approach to confidence interval estimation. Health Economics 1997; 6 (4): 327-340
8. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 1999; 18: 341-364
9. Cook JR, Heyse JF. Use of an angular transformation for ratio estimation in cost- effectiveness analysis. Statistics in Medicine 2000; 19 (21): 2989-3003
10. Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 2004; 13 (5): 437-452
11. rd Edition, Oxford: Oxford University Press, 2005
12. Emnid Institut. Gesunder Rücken/Gesund am Computer: Ergebnisse einer Repräsentativerhebung im Auftrag des Bundesverbandes der Betriebskrankenkassen zum Thema "Rücken". Bielefeld, 1998
13. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics 2001; 10 (8): 779-787
14. Goossens ME, Van Rutten-Molken MP, Kole-Snijders AM et al. Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial. Health Economics 1998; 7(1): 39-51
15. van Hout BA, Al MJ, Gordon GS et al. Costs, effects and C/E-ratios alongside a clinical trial. Health Economics 1994; 3 (5): 309-319
16. Hutubessy RC, Baltussen RM, Evans DB et al. Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Economics 2001; 10(5): 473-477
17. John J, Leidl R. Zur Bedeutung von ökonomischen Evaluationen beim Ein- und Ausschluss von Leistungen. Sozialer Fortschritt 2004; 53 (8/9): 219-228
18. Leidl R. Der Effizienz auf der Spur: Eine Einführung in die ökonomische Evaluation. In: Schwartz FW, Badura B, Busse R, Leidl R, Raspe H, Siegrist J, Walter U (Hrsg). Das Public Health Buch. Gesundheit und Gesundheitswesen. 2. Auflage. München: Urban & Fischer, 2003: 461-484
19. Niebuhr D, Rothgang H, Wasem J et al. Die Bestimmung des Leistungskataloges in der gesetzlichen Krankenversicherung. Bd. 108, Düsseldorf: Edition Hans-Böckler-Stiftung, 2004
20. O'Brien B, Sculpher M. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules. Medical Care 2000; 38 (5): 460-468
21. O'Brien BJ, Gertsen K, Willan AR et al. Is there a kink in consumers' threshold value for cost-effectiveness in health care? Health Economics 2002; 11 (2): 175-180
22. Schweikert S, Leidl R. Ökonomische Evaluation der intensivierten psychologischen Betreuung und der herkömmlichen Behandlung von Patienten mit chronischen Rückenschmerzen. In: Leidl R, Schweikert S (Hrsg). Projekt 4: Gesundheitsökonomische Analysen. Endbericht- Rehabilitationswissenschaftlicher Forschungsverbund Ulm, 2002: 1-75
23. Seitz R, Leidl R, Jacobi E. Die psychometrischen Eigenschaften des EuroQol bei Rehabilitanden mit Erkrankungen des Stütz- und Bewegungsapparates. Zeitschrift für Gesundheitswissenschaften 1999; 7 (3): 210-232
24. Sendi P, Gafni A, Birch S. Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health Economics 2002; 11 (1): 23-31
25. Towse A. What is NICE'S threshold? An external view. Chapter 2. In: Devlin N, Towse A (eds). London: Cost Effectiveness Thresholds: Economic and Ethical Issues, Kings Fund/Office for Health Economics, 2002
26. van Tulder MW. Die Behandlung von Rückenschmerzen. Mythen und Fakten, Schmerz 2001; 15: 499-503
27. Zethraeus N, Johannesson M, Jonsson B et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003; 21: 39-48